Pharmaceutical composition for preventing or treating cancer
US8987425B2 · kind B2 · utility
2Cited by
1References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 25, 2012 |
| Grant date | Mar 24, 2015 |
| Priority date | — |
| Expiry date | Jul 25, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides a fusion protein comprising (a) a first protein comprising a polypeptide which specifically binds to Annexin A1 and (b) a second protein comprising a polypeptide which induces a cytotoxic activity of a cytotoxic lymphocyte, pharmaceutical compositions comprising the fusion protein, and methods of treating or preventing cancer by administering the pharmaceutical compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.